These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9372996)

  • 1. Economics of treating heart failure.
    Mark DB
    Am J Cardiol; 1997 Oct; 80(8B):33H-38H. PubMed ID: 9372996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic implications of treatment guidelines for congestive heart failure.
    Shibata MC; Nilsson C; Hervas-Malo M; Jacobs P; Tsuyuki RT
    Can J Cardiol; 2005 Dec; 21(14):1301-6. PubMed ID: 16341301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of angiotensin-converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology.
    Gambassi G; Lapane KL; Sgadari A; Carbonin P; Gatsonis C; Lipsitz LA; Mor V; Bernabei R
    Arch Intern Med; 2000 Jan; 160(1):53-60. PubMed ID: 10632305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From digoxin to angiotensin-converting enzyme inhibitors: issues in pharmacotherapy for congestive heart failure.
    Hackenbruck HA
    Clin Excell Nurse Pract; 2000 Jul; 4(4):197-204. PubMed ID: 11261079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacoeconomic considerations in assessing and selecting congestive heart failure therapies.
    Levy E; Levy P
    Pharmacoeconomics; 2002; 20(14):963-77. PubMed ID: 12403637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin converting enzyme inhibitors versus digoxin for the treatment of congestive heart failure.
    Crozier I; Ikram H
    Drugs; 1992 May; 43(5):637-50. PubMed ID: 1379144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community pharmacist outreach program directed at physicians treating congestive heart failure.
    Turner CJ; Parfrey P; Ryan K; Miller R; Brown A
    Am J Health Syst Pharm; 2000 Apr; 57(8):747-52. PubMed ID: 10786260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The treatment of heart decompensation using angiotensin converting enzyme inhibitors. Pharmaco-economic aspects].
    Kulbertus H
    Rev Med Liege; 1998 May; 53(5):255-8. PubMed ID: 9689878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of randomized trials of digoxin therapy in patients with chronic heart failure.
    Gheorghiade M; Zarowitz BJ
    Am J Cardiol; 1992 Jun; 69(18):48G-62G; discussion 62G-63G. PubMed ID: 1626492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of heart failure among very old persons living in long-term care: has the voice of trials spread? The SAGE Study Group.
    Gambassi G; Forman DE; Lapane KL; Mor V; Sgadari A; Lipsitz LA; Bernabei R
    Am Heart J; 2000 Jan; 139(1 Pt 1):85-93. PubMed ID: 10618567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Digoxin and angiotensin-converting enzyme inhibitors in the treatment of chronic congestive heart failure].
    Thery C
    Therapie; 1994; 49(3):211-8. PubMed ID: 7878586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fundamental role of angiotensin-converting enzyme inhibitors in the management of congestive heart failure.
    Opie LH
    Am J Cardiol; 1995 Jun; 75(18):3F-6F. PubMed ID: 7778532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Trends in pharmacological treatment of congestive heart failure].
    Halawa B
    Pol Merkur Lekarski; 1999 Mar; 6(33):152-6. PubMed ID: 10365602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibitors in congestive heart failure.
    Deedwania PC
    Arch Intern Med; 1990 Sep; 150(9):1798-805. PubMed ID: 2132302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacologic treatment of chronic congestive heart failure].
    Halawa B
    Przegl Lek; 1996; 53(3):119-23. PubMed ID: 8754362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug therapy for congestive heart failure. Appropriate choices can prolong life.
    Sorrentino MJ
    Postgrad Med; 1997 Jan; 101(1):83-6, 89-90, 93-4. PubMed ID: 9008690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost effectiveness of carvedilol for heart failure.
    Delea TE; Vera-Llonch M; Richner RE; Fowler MB; Oster G
    Am J Cardiol; 1999 Mar; 83(6):890-6. PubMed ID: 10190405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the role of angiotensin-converting enzyme inhibitors in congestive heart failure and after myocardial infarction?
    Nelson KM; Yeager BF
    Ann Pharmacother; 1996 Sep; 30(9):986-93. PubMed ID: 8876861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of angiotensin-converting enzyme inhibitor underdosing on rehospitalization rates in congestive heart failure.
    Luzier AB; Forrest A; Adelman M; Hawari FI; Schentag JJ; Izzo JL
    Am J Cardiol; 1998 Aug; 82(4):465-9. PubMed ID: 9723634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of physician use of angiotensin converting enzyme inhibitors in the inpatient treatment of congestive heart failure.
    Ghali JK; Giles T; Gonzales M; Horswell R; Kumar S; Lejuene A; Livaudais GF; Sarkar IC
    J La State Med Soc; 1997 Dec; 149(12):474-84. PubMed ID: 9425858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.